World High Life Plc (WRHLF“>AQSE:LIFE)(WRHLF“>OTCQB:WRHLF) announces that World High Life wholly owned subsidiary, Love Hemp, has developed and launched a new brand to market, Buzz Leaf, which is targeted to a younger demographic (ages 21-34) in order to grow market share

Love Hemp’s new product development strategy is central to the company’s growth plan, building on the strength of the Love Hemp branded product range, the focus is to develop brands to engage new consumers, increasing overall market share.


Buzz Leaf products have been developed and designed to connect with a younger demographic, giving the brand more freedom on the types of product categories it includes, from vapes to full spectrum CBD oils and enhancement products, for example benefit led products such as a hangover remedy, and cognition and libido enhancers.

The new Buzz Leaf CBD range of products includes the release of four broad spectrum CBD infused e-liquids with added terpenes and will be available exclusively at www.cbdoilsuk.com.

The e-liquids feature exotic flavours including Horny Mango & Pineapple Express, Blue Mist & Blue Dream, Tigers Blood & Watermelon OG and Lykos & Grandaddy Purple. The CBD infused e-liquids are priced at £24.99 for 30ml and contain 500mg of CBD.

Whilst all flavours are expected to be popular with both new and existing CBD vapers, clear winners are Horny Mango & Pineapple Express as well as Blue Mist & Blue Dream. The e-liquids are a welcome new addition to the CBDOilsUK range of products, appealing to a diverse audience, whilst building on the already successful range of Love Hemp e-liquids the online retailer stocks.

“With consumers demanding more high quality products at reasonable prices, our goal is to not only deliver strong margins for Buzz Leaf, but also provide competitively priced, high quality product options for a wider range of consumers – we really want to have something for everyone,” says Tony Calamita, CEO at Love Hemp.

In addition to the launch of the four broad spectrum CBD infused e-liquids with added terpenes, Buzz Leaf is planning to launch a full range of CBD products including capsules and oils. For further information on Buzz Leaf, visit www.cbdoilsuk.com.

The Directors of the Company accept responsibility for the contents of this announcement.

For further information please contact:

David Stadnyk
Founder & CEO
North America: 1 (236) 521-7211
North America toll-free: 1 (888) 616-WRHLF (9745)
+44 (0)
7926 397 675
info@worldhighlife.uk
AQSE Corporate Adviser
Mark Anwyl/Allie Feuerlein
Peterhouse Capital Limited
+44 (0) 20 7469 0930
ma@peterhousecap.com
af@peterhousecap.com
Financial PR
Camilla Horsfall/Megan Ray
Blytheweigh
+44 (0) 20 7138 3224
Camilla.horsfall@blytheweigh.com
Megan.Ray@blytheweigh.com

For more information on World High Life please visit: www.worldhighlife.uk

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Cautionary Note Regarding Forward Looking Information

We seek safe harbour. Some statements contained in this news release are “forward looking information” within the meaning of securities laws. Forward looking information include, but are not limited to, statements regarding the use of proceeds of the non-brokered private placement and payment of the debt settlements. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, “believes” or variations of such words and phrases (including negative or grammatical variations) or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” or the negative connotation thereof. Investors are cautioned that forward-looking information is inherently uncertain and involves risks, assumptions and uncertainties that could cause actual results to differ materially. There can be no assurance that future developments affecting the Company will be those anticipated by management. The forward-looking information contained in this press release constitutes management’s current estimates, as of the date of this press release, with respect to the matters covered thereby. We expect that these estimates will change as new information is received. We do not undertake to update any estimate at any particular time or in response to any particular event, except as required by law.

SOURCE: World High Life Plc

View source version on accesswire.com:
https://www.accesswire.com/597692/Love-Hemp-Launches-New-Consumer-Brand-Buzz-Leaf-Targeted-at-Younger-Demographic-to-Grow-Market-Share

ACCESSWIRE
July 16, 2020 – 6:00 AM PDT
News by QuoteMedia

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.

The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.

Keep reading... Show less

HempFusion Wellness Inc. ( TSX:CBD.U ) ( FWB:8OO ) (“ HempFusion ” or the “ Company ”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ ETFs ”), AdvisorShares Pure US Cannabis ETF ( NYSE:MSOS ) and AdvisorShares Pure Cannabis ETF ( NYSE:YOLO ).

AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“ AUM ”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.

Keep reading... Show less